F
Friedrich K. Port
Researcher at University of Michigan
Publications - 409
Citations - 54004
Friedrich K. Port is an academic researcher from University of Michigan. The author has contributed to research in topics: Dialysis & Hemodialysis. The author has an hindex of 107, co-authored 403 publications receiving 50165 citations. Previous affiliations of Friedrich K. Port include Amgen & Michigan State University.
Papers
More filters
Journal ArticleDOI
DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
Angelo Karaboyas,Hairong Xu,Hal Morgenstern,Francesco Locatelli,Michel Jadoul,Kosaku Nitta,Indranil Dasgupta,Francesca Tentori,Friedrich K. Port,Bruce M. Robinson +9 more
TL;DR: A relatively small survival benefit of RAASi and other antihypertensive agents in hemodialysis patients is suggested, though randomized prospective studies are needed to potentially change prescribing criteria.
Journal ArticleDOI
Outcome of end-stage renal disease in patients with rare causes of renal failure. II. Renal or systemic neoplasms.
TL;DR: A large experience with patients with end-stage renal disease (ESRD) whose primary cause was considered multiple myeloma, renal cell carcinoma and amyloidosis is described, which provides some assistance to physicians when advising their patients with these rare conditions.
Journal ArticleDOI
Lithium therapy during maintenance hemodialysis.
Journal ArticleDOI
Recipient age as an independent risk factor for chronic renal allograft failure.
Herwig Ulf Meier-Kriesche,A.O Ojo,J.A Arndorfer,Friedrich K. Port,J. C. Magee,Alan B. Leichtman,J. D. Punch,Bruce Kaplan +7 more
Journal ArticleDOI
Reuse of dialyzers and clinical outcomes: Fact or fiction
TL;DR: There has been a significant increase in the practice of dialyzer reuse in the United States, and reuse is greatest in freestanding for-profit units (87%) and freestanded nonprofit (FSNP) units (77%) and least in hospital units (49%).